Abstract:Objective Vanishing white matter disease,inherited with autosomal recessiveu manner,is supposed to be one of the most prevalent inherited leukoencephalopathy in childhood.It is the first known hereditary human disease due to the direct defects in translation initiation process,with the gene defects in EIF2B1-5,encoding the five subunits of eukaryotic translation initiation factor 2B(eIF2B α,β,γ,δ and e) identified in 2001 to 2002.The pathogenesis of vanishing white matter disease is still far from well understood.Methods The analysis of clinical features and EIF2B1-5 mutation screening was performed in 12 Chinese children,who fulfilled the diagnostic criteria clinically proposed by van der Knaap.Genomic DNA was extracted from peripheral leukocytes.Mutation screening for EIF2B5 was carried out in each patient firstly,followed by screening for EIF2B4,EIF2B2,EIF2B3 and EIF2B1.For novel EIF2B5 mutations identified,in vitro functional study was carried out in transfected HEK 293 cells.Results These patients,consisting of 8 boys and 4 girls,came from 12 core families.All patients presented with classical phenotypes.All individuals were free of symptoms at birth and their developmental milestones were normal or mildly delayed.The symptoms began to appear from 1 year and 6 months to 6 years and 8 months of age,usually with subacute onset.The initial symptom was usually movement disturbance.The illness course was 9 months to 7 years until the last follow up.In all cases,the disease progressed,and with episodic aggravation in 7 cases.The brain MRI showed symmetric and diffuse abnormal signal in periventricular white matter in all cases,with a part having signal intensity close to cerebrospinal fluid on T1-weighted,T2-weighted and flair images.Sixteen mutations were identified in EIF2B5,EIF2B3 and EIF2B2,consisting of 9 novel mutations and 7 mutations reported previously.Nine novel mutations included 7 missense mutations(EIF2B5:c.185AT,p.D62V;c.1004GC,p.C335S;c.1126AG,p.N376D;EIF2B3:c.140GA,p.G47E;c.1037TC,p.I346T;EIF2B2:c.254 TA,p.V85E;c.922 GA,p.V308M),1 nonsense mutation(EIF2B5:c.805CT,R269X),and 1 deletion mutation(EIF2B5:c.1827-1838del,p.S610-D613del).EIF2B3 mutation,accounting for 18.8% of total mutations found in this study,was more prevalent than previous reports in Caucasian population(7%).A hot spot mutation in EIF2B3 was identified.Further functional study on five novel EIF2B5 mutations revealed that p.R296X and p.S610-D613del mutations resulted in significant loss of the mutant protein.Conclusions Vanishing white matter disease patients with mutations were firstly reported in China.Our study identified 9 novel EIF2B mutations and revealed the unique mutation spectrum in Chinese patients.EIF2B5 mutations,p.R296X and p.S610-D613del,were probably the cause of loss of protein function.Further functional analysis of other mutations is ongoing.

Research Advances in the Clinical Genetics of Leukodystrophy in Children

New Clinical Characteristics and Novel Pathogenic Variants of Patients with Hereditary Leukodystrophies

Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies

The clinical and genetic features of early-onset globoid cell leukodystrophy in one boy

The Use Of Targeted Genomic Capture And Massively Parallel Sequencing In Diagnosis Of Chinese Leukoencephalopathies

Currently Clinical Views On Genetics Of Wilson'S Disease

Approaches to diagnosis for individuals with a suspected inherited white matter disorder

Etiological spectrum of pediatric onset leukodystrophies and genetic leukoencephalopathies: the five-year experience of a tertiary care centre in southern India

Genetic Advances in Neurodevelopmental Disorders

Progression in the Imaging of Leukodystrophy

Targeted Capture and Massively Parallel Sequencing to Identify Atypical Leukoencephalopathy in 48 Chinese Patients (P3.265)

Hypomyelinating Disorders In China: The Clinical And Genetic Heterogeneity In 119 Patients

Targeted Capture and Massively Parallel Sequencing to Identify Atypical Leukoencephalopathy in 48 Chinese Patients (I7.011)

Advances in Personalized Diagnosis and Treatment of Treatable Genetic Diseases of Pediatric Neurology in Precision Medicine Period

Emerging Role of Ubiquitin Proteasome System and Autophagy in Pediatric Demyelinating Leukodystrophies and Therapeutic Opportunity

Genetic Analysis of 20 Patients with Hypomyelinating Leukodystrophy by Trio-Based Whole-Exome Sequencing

Genetical and Clinical Study on Twelve Chinese Children with Leukoencephalopathy with Vanishing White Matter Disease

Follow-Up of Natural History of 17 Chinese Patients with Early Childhood-Onset Leukoencephalopathy with Vanishing White Matter and Analysis of Their Genotype-Phenotype

Genetic Testing in Children with Developmental and Epileptic Encephalopathies: A Review of Advances in Epilepsy Genomics

Clinical analysis of 13 cases of unrecognized infantile leukoencephalopathy

General approach to treatment of genetic leukoencephalopathies in children and adults